DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Pisters R, Nieuwlaat R, Lane DA. et al.
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.
Thromb Haemost 2013;
109: 328-336.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.